Certified Asthma Educator (AE-C)PROCTORED
EXAM WITH NGN ACTUAL QUESTIONS AND
CORRECT ANSWERS (VERIFIED ANSWERS) PLUS
RATIONALES Q&A
,Section 1: The Asthma Condition (Questions 1-20)
1. Asthma is primarily characterized by which pathophysiological process?
A. Irreversible alveolar destruction
B. Chronic airway inflammation and hyperresponsiveness
C. Excessive, thick mucus production due to CFTR gene mutation
D. Acute infectious process in the lung parenchyma
Answer: B
Rationale: Asthma is defined by chronic inflammation of the airways, leading to bronchial hyperresponsiveness, airflow
obstruction, and respiratory symptoms. Option A describes emphysema, C describes cystic fibrosis, and D describes
pneumonia.
,2. A hallmark symptom differentiating asthma from other respiratory conditions is:
A. Productive cough with purulent sputum
B. Hemoptysis
C. Symptom variability over time and in intensity
D. Constant, unchanging dyspnea
Answer: C
Rationale: The key feature of asthma is the variability of symptoms such as wheeze, shortness of breath, chest tightness,
and cough, which can change in intensity over time, often worse at night or early morning.
3. Which of the following is a key cellular mediator in the early-phase asthmatic response, triggered by allergen exposure?
A. Neutrophil
B. Mast cell
C. Macrophage
D. Eosinophil
Answer: B
, Rationale: The early asthmatic response (within minutes of allergen exposure) is primarily mediated by mast cells
degranulating and releasing preformed mediators like histamine. Eosinophils are the hallmark of the late-phase response
(4-6 hours later).
4. Airway remodeling in chronic, severe asthma can lead to:
A. Complete reversibility of airflow limitation
B. A fixed, or only partially reversible, airflow obstruction
C. Increased response to bronchodilator therapy
D. Ciliary dyskinesia
Answer: B
Rationale: Chronic inflammation can lead to structural changes (airway remodeling) including sub-basement membrane
thickening, smooth muscle hypertrophy, and angiogenesis, resulting in a component of fixed airflow obstruction that does
not fully reverse with bronchodilators.
5. A patient’s spirometry shows a reduced FEV1/FVC ratio, but FEV1 improves by 15% and 250 mL after albuterol. This
indicates:
A. Restrictive lung disease
EXAM WITH NGN ACTUAL QUESTIONS AND
CORRECT ANSWERS (VERIFIED ANSWERS) PLUS
RATIONALES Q&A
,Section 1: The Asthma Condition (Questions 1-20)
1. Asthma is primarily characterized by which pathophysiological process?
A. Irreversible alveolar destruction
B. Chronic airway inflammation and hyperresponsiveness
C. Excessive, thick mucus production due to CFTR gene mutation
D. Acute infectious process in the lung parenchyma
Answer: B
Rationale: Asthma is defined by chronic inflammation of the airways, leading to bronchial hyperresponsiveness, airflow
obstruction, and respiratory symptoms. Option A describes emphysema, C describes cystic fibrosis, and D describes
pneumonia.
,2. A hallmark symptom differentiating asthma from other respiratory conditions is:
A. Productive cough with purulent sputum
B. Hemoptysis
C. Symptom variability over time and in intensity
D. Constant, unchanging dyspnea
Answer: C
Rationale: The key feature of asthma is the variability of symptoms such as wheeze, shortness of breath, chest tightness,
and cough, which can change in intensity over time, often worse at night or early morning.
3. Which of the following is a key cellular mediator in the early-phase asthmatic response, triggered by allergen exposure?
A. Neutrophil
B. Mast cell
C. Macrophage
D. Eosinophil
Answer: B
, Rationale: The early asthmatic response (within minutes of allergen exposure) is primarily mediated by mast cells
degranulating and releasing preformed mediators like histamine. Eosinophils are the hallmark of the late-phase response
(4-6 hours later).
4. Airway remodeling in chronic, severe asthma can lead to:
A. Complete reversibility of airflow limitation
B. A fixed, or only partially reversible, airflow obstruction
C. Increased response to bronchodilator therapy
D. Ciliary dyskinesia
Answer: B
Rationale: Chronic inflammation can lead to structural changes (airway remodeling) including sub-basement membrane
thickening, smooth muscle hypertrophy, and angiogenesis, resulting in a component of fixed airflow obstruction that does
not fully reverse with bronchodilators.
5. A patient’s spirometry shows a reduced FEV1/FVC ratio, but FEV1 improves by 15% and 250 mL after albuterol. This
indicates:
A. Restrictive lung disease
